Stock Scorecard
Stock Summary for IQVIA Holdings Inc (IQV) - $187.22 as of 9/12/2025 9:03:00 PM EST
Total Score
9 out of 30
Safety Score
56 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for IQV
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for IQV
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for IQV
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for IQV
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for IQV (56 out of 100)
| Stock Price Rating (Max of 10) | 10 |
| Historical Stock Price Rating (Max of 10) | 10 |
| Stock Price Trend (Max of 10) | 2 |
| Book Value (Max of 10) | 8 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 3 |
| Trading Volume (Max of 10) | 8 |
| Price to Earnings (Max of 10) | 6 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for IQV
Financial Details for IQV
Company Overview |
|
|---|---|
| Ticker | IQV |
| Company Name | IQVIA Holdings Inc |
| Country | USA |
| Description | IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology and clinical research. It is a provider of biopharmaceutical development and commercial outsourcing services, focused primarily on Phase I-IV clinical trials and associated laboratory and analytical services, including consulting services. |
| Sector Name | HEALTHCARE |
| Industry Name | DIAGNOSTICS & RESEARCH |
| Most Recent Quarter | 6/30/2025 |
| Next Earnings Date | 10/30/2025 |
Stock Price History |
|
| Last Day Price | 187.22 |
| Price 4 Years Ago | 282.14 |
| Last Day Price Updated | 9/12/2025 9:03:00 PM EST |
| Last Day Volume | 945,693 |
| Average Daily Volume | 1,288,828 |
| 52-Week High | 248.03 |
| 52-Week Low | 134.65 |
| Last Price to 52 Week Low | 39.04% |
Valuation Measures |
|
| Trailing PE | 26.65 |
| Industry PE | 39.68 |
| Sector PE | 40.86 |
| 5-Year Average PE | 26.54 |
| Free Cash Flow Ratio | 15.61 |
| Industry Free Cash Flow Ratio | 81.55 |
| Sector Free Cash Flow Ratio | 29.37 |
| Current Ratio Most Recent Quarter | 0.84 |
| Total Cash Per Share | 11.99 |
| Book Value Per Share Most Recent Quarter | 33.99 |
| Price to Book Ratio | 5.58 |
| Industry Price to Book Ratio | 244.23 |
| Sector Price to Book Ratio | 32.27 |
| Price to Sales Ratio Twelve Trailing Months | 1.99 |
| Industry Price to Sales Ratio Twelve Trailing Months | 4.38 |
| Sector Price to Sales Ratio Twelve Trailing Months | 19.72 |
| Analyst Buy Ratings | 14 |
| Analyst Strong Buy Ratings | 2 |
Share Statistics |
|
| Total Shares Outstanding | 170,000,000 |
| Market Capitalization | 31,827,400,000 |
| Institutional Ownership | 102.10% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | -21.80% |
| Annual Earnings Growth | 1.10% |
| Reported EPS 12 Trailing Months | 6.90 |
| Reported EPS Past Year | 4.24 |
| Reported EPS Prior Year | 9.15 |
| Net Income Twelve Trailing Months | 1,237,000,000 |
| Net Income Past Year | 1,373,000,000 |
| Net Income Prior Year | 1,358,000,000 |
| Quarterly Revenue Growth YOY | 5.30% |
| 5-Year Revenue Growth | 6.80% |
| Operating Margin Twelve Trailing Months | 13.40% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 2,039,000,000 |
| Total Cash Past Year | 1,702,000,000 |
| Total Cash Prior Year | 1,376,000,000 |
| Net Cash Position Most Recent Quarter | -12,138,000,000 |
| Net Cash Position Past Year | -11,136,000,000 |
| Long Term Debt Past Year | 12,838,000,000 |
| Long Term Debt Prior Year | 12,955,000,000 |
| Total Debt Most Recent Quarter | 14,177,000,000 |
| Equity to Debt Ratio Past Year | 0.32 |
| Equity to Debt Ratio Most Recent Quarter | 0.29 |
| Total Stockholder Equity Past Year | 6,067,000,000 |
| Total Stockholder Equity Prior Year | 6,112,000,000 |
| Total Stockholder Equity Most Recent Quarter | 5,778,000,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 2,010,000,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 11.82 |
| Free Cash Flow Past Year | 2,114,000,000 |
| Free Cash Flow Prior Year | 1,500,000,000 |
Options |
|
| Put/Call Ratio | 24.15 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 1.35 |
| MACD Signal | 2.10 |
| 20-Day Bollinger Lower Band | 128.54 |
| 20-Day Bollinger Middle Band | 167.23 |
| 20-Day Bollinger Upper Band | 205.92 |
| Beta | 1.32 |
| RSI | 48.65 |
| 50-Day SMA | 184.50 |
| 150-Day SMA | 207.02 |
| 200-Day SMA | 212.24 |
System |
|
| Modified | 9/11/2025 2:39:38 AM EST |